<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Plastic and Reconstructive Surgery</title>
    <link>http://repub.eur.nl/res/org/9812/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Heparan Sulfate Proteoglycan Mimetics Promote Tissue Regeneration: An Overview (In Book)</title>
      <link>http://repub.eur.nl/res/pub/37168/</link>
      <pubDate>2012-09-05T00:00:00Z</pubDate>
      <description>
        
        
      </description>
      <author>Neck, J.W. van</author> <author>Tuk, B.</author> <author>Barritault, D.</author> <author>Tong, M.</author>
    </item> <item>
      <title>Vascularization of prevascularized and non-prevascularized fibrin-based human adipose tissue constructs after implantation in nude mice (Article)</title>
      <link>http://repub.eur.nl/res/pub/23731/</link>
      <pubDate>2012-03-01T00:00:00Z</pubDate>
      <description>
        
        Adipose regeneration strategies have been hampered by the inability to supply an adequate vascular supply following implantation. Vascularization in vitro, also called prevascularization, is a promising method that could promote the vascularization of engineered adipose tissue constructs upon implantation. In this study we compared the ability of prevascularized-to-non-prevascularized fibrin-based human adipose tissue to promote vascularization. Human adipose tissue-derived stromal cells (ASCs) and different mixtures (1:1, 1:2 and 1:5) of ASCs with human umbilical vein endothelial cells (HUVECs) were cultured in fibrin at two different densities (1.0 × 106and 10 × 106cells/ml) for 7 days. Histological analysis revealed that prevascular structures formed in 1:5 ASC/HUVEC fibrin-based constructs seeded with a total of 10 × 106cells/ml. These constructs and ASC-only constructs were implanted subcutaneously in athymic mice for 7 days and generated lipid-containing grafts. The numbers and densities of blood vessels within the ASC/HUVEC constructs were similar to those of ASC-only constructs. Furthermore, immunostaining studies demonstrated human-derived vasculature within a few of the ASC/HUVEC and ASC-only constructs. A subset of this human-derived vasculature contained erythrocytes, indicating integration with the host vasculature. In conclusion, our study indicated no difference in the rate of vascularization of prevascularized ASC/HUVEC and non-prevascularized ASC-only fibrin-based constructs, suggesting that prevascularization of these fibrin-based constructs does not promote vascularization. Our results further indicated that not only endothelial cells, but also ASCs may contribute to the formation of vascular lumina upon implantation. This finding is interesting, since it demonstrates the possibility of vascularized adipose tissue engineering from a single cell source. 
      </description>
      <author>Verseijden, F.</author> <author>Posthumus-van Sluijs, S.J.</author> <author>Neck, J.W. van</author> <author>Hofer, S.O.P</author> <author>Hovius, S.E.R.</author> <author>Osch, G.J.V.M. van</author>
    </item> <item>
      <title>Characterization of a three-dimensional mucosal equivalent: Similarities and differences with native oral mucosa (Article)</title>
      <link>http://repub.eur.nl/res/pub/23699/</link>
      <pubDate>2012-02-01T00:00:00Z</pubDate>
      <description>
        
        The aim of this study was to create and characterize a tissue-engineered mucosal equivalent (TEM) that closely resembles native mucosa. TEM consists of human primary keratinocytes and fibroblasts isolated from biopsies taken from healthy donors and seeded onto a de-epidermized dermis and cultured for 14 days at the air/liquid interface. The structure of TEM was examined and compared with native nonkeratinizing oral mucosa (NNOM). The various components of the newly formed epidermal layer, basement membrane and underlying connective tissue were analyzed using immunohistochemistry. The mucosal substitute presented in this study showed a mature stratified squamous epithelium that was similar to that of native oral mucosa, as demonstrated by K19, desmoglein-3 and involucrin staining. In addition, the expression of basement membrane components collagen type IV, laminin-5 and integrin α6 and β4 in TEM proved to be consistent with native oral mucosa. The expression of PAS, Ki67, K10 and K13, however, appeared to be different in TEM compared to NNOM. Nevertheless, the similarities with native oral mucosa makes TEM a promising tool for studying the biology of mucosal pathologies such as oral mucositis or fibrosis as well as the development of new therapies. Copyright 
      </description>
      <author>Tra, W.M.W.</author> <author>Neck, J.W. van</author> <author>Hovius, S.E.R.</author> <author>Osch, G.J.V.M. van</author> <author>Perez-Amodio, S.</author>
    </item> <item>
      <title>Heparan sulfate glycosaminoglycan mimetic improves pressure ulcer healing in a rat model of cutaneous ischemia-reperfusion injury (Article)</title>
      <link>http://repub.eur.nl/res/pub/26675/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>
        
        Pressure ulcers are a major clinical problem, with a large burden on healthcare resources. This study evaluated the effects of the heparan sulfate glycosaminoglycan mimetic, OTR4120, on pressure ulceration and healing. Ischemia-reperfusion (I-R) was evoked to induce pressure ulcers by external clamping and then removal of a pair of magnet disks on rat dorsal skin for a single ischemic period of 16 hours. Immediately after magnet removal, rats received an intramuscular injection of OTR4120 weekly for up to 1 month. During the ischemic period, normal skin perfusion was reduced by at least 60% and at least 20-45% reperfused into the ischemic region after compression release. This model caused sustained skin incomplete necrosis for up to 14 days and led to grade 2-3 ulcers. OTR4120 treatment decreased the area of skin incomplete necrosis and degree of ulceration. OTR4120 treatment also reduced inflammation and increased angiogenesis. In OTR4120-treated ulcers, the contents of vascular endothelial growth factor, platelet-derived growth factor, and transforming growth factor beta-1 were increased. Moreover, OTR4120 treatment promoted early expression of alpha-smooth muscle actin and increased collagen biosynthesis. Long-term restoration of wounded tissue biomechanical strength was significantly enhanced after OTR4120 treatment. Taken together, we conclude that OTR4120 treatment reduces pressure ulcer formation and potentiates the internal healing bioavailability. 
      </description>
      <author>Tong, M.</author> <author>Tuk, B.</author> <author>Hekking, I.M.</author> <author>Aleumeekers, M.M.</author> <author>Boldewijn, M.B.</author> <author>Hovius, S.E.R.</author> <author>Neck, J.W. van</author>
    </item> <item>
      <title>Biomechanical evaluation of the Pulvertaft versus the 'wrap around' tendon suture technique (Article)</title>
      <link>http://repub.eur.nl/res/pub/26696/</link>
      <pubDate>2011-07-01T00:00:00Z</pubDate>
      <description>
        
        The purpose of this study was to compare the biomechanical properties of a novel wrap around tendon repair method with those of the standard Pulvertaft technique used for tendon reconstructions. Seventy-two porcine extensor tendons were used to create 36 reconstructions in six sets of six repairs, each using one of the two surgical techniques with differing lengths of the reconstructions. All the reconstructions were tested in vitro by cyclic tensile loading, resulting in the time-zero strength. When only the size of the repair and the strength were compared, and length of the reconstruction was not taken in consideration, the 'wrap around' reconstructions were of similar strength but less bulky than the Pulvertaft repairs. In conclusion, the 'wrap around' technique gives a thinner reconstruction which is as strong as, or stronger than the Pulvertaft technique, depending on the amount of weaves. 
      </description>
      <author>Fuchs, S.P.</author> <author>Walbeehm, E.T.</author> <author>Hovius, S.E.R.</author>
    </item> <item>
      <title>Placental vascularization in early onset small for gestational age and preeclampsia (Article)</title>
      <link>http://repub.eur.nl/res/pub/26350/</link>
      <pubDate>2011-06-01T00:00:00Z</pubDate>
      <description>
        
        The objective was to determine whether chorionic villous vascularization is diminished in cases of early onset (&lt;34 weeks) small for gestational age (SGA) and/or preeclampsia (PE). Placental morphometrical measurements were performed in 4 gestational-age-matched groups complicated by SGA, SGA with PE, PE, and spontaneous preterm delivery without SGA or PE as the reference group. Using a video image analysis system, in randomly selected intermediate and terminal villi, the stromal area and the following villous vascular parameters were manually traced and analyzed: number of total, centrally and peripherally localized vessels, vascular area, and vascular area density. No differences were observed in intermediate and terminal villous vascular area. Preeclampsia was associated with smaller terminal villous stromal area (reference 2299 μm2, SGA 2412 μm2, SGA + PE 2073 μm2, and PE 2164 μm2, P =.011), whereas SGA was associated with an increased terminal villous vascular area density (reference 26.1%, SGA 35.7%, SGA + PE 33.4%, and PE 32.0%, P =.029). Compared with preserved flow, lower terminal villous vascular area density was found in cases with absent or reversed end-diastolic (ARED) umbilical artery flow (39.3% vs 30.3%, P =.013). These data demonstrate that villous vascularization was not influenced by PE, whereas in terminal villi an increased vascular area density was associated with SGA. Lower terminal villous vascular area density was associated with ARED flow in SGA pregnancies, indicating an increased risk of fetal compromise. 
      </description>
      <author>Oppenraaij, R.H.F. van</author> <author>Bergen, N.E.</author> <author>Duvekot, J.J.</author> <author>Krijger, R.R. de</author> <author>Ir, W.C.J.H.</author> <author>Steegers-Theunissen, R.P.M.</author> <author>Exalto, N.</author>
    </item> <item>
      <title>Overexpression of the natural antisense hypoxia-inducible factor-1α transcript is associated with malignant pheochromocytoma/paraganglioma (Article)</title>
      <link>http://repub.eur.nl/res/pub/26702/</link>
      <pubDate>2011-06-01T00:00:00Z</pubDate>
      <description>
        
        Paragangliomas (PGLs) have widely different metastastic potentials. Two different types of PGLs can be defined by expression profiling. Cluster 1 PGLs exhibit VHL and/or succinate dehydrogenase (SDH) mutations and a pseudohypoxic phenotype. RET and neurofibromatosis type 1 (NF1) mutations occur in cluster 2 tumors characterized by deregulation of the RAS/RAF/MAP kinase signaling cascade. Sporadic PGLs can exhibit either profile. During sustained hypoxia, a natural antisense transcript of hypoxia-inducible factor 1 (aHIF) is expressed. The role of aHIF in the metastatic potential of PGL has not yet been investigated. The aim was to test the hypothesis that genotype-specific overexpression of aHIF is associated with an increased metastatic potential. Tumor samples were collected from87 patients with PGL. Quantitative PCR was performed for aHIF, vascular endothelial growth factor (VEGF), aquaporin 3, cytochrome b561, p57Kip2, slit homolog 3, and SDHC. Expression was related to mutation status, benign versus malignant tumors, and metastasis-free survival. We found that both aHIF and VEGF were overexpressed in cluster 1 PGLs and inmetastatic tumors. In contrast, slit homolog 3, p57Kip2, cytochrome b561, and SDHC showed overexpression in non-metastatic tumors, whereas no such difference was observed for aquaporin 3. Patients with higher expression levels of aHIF and VEGF had a significantly decreased metastasis free survival. Higher expression levels of SDHC are correlated with an increased metastasis-free survival. In conclusion, we not only demonstrate a higher expression of VEGF in cluster 1 PGL, fitting a profile of pseudohypoxia and angiogenesis, but also of aHIF. Moreover, overexpression of aHIF and VEGF marks a higher metastatic potential in PGL. 
      </description>
      <author>Span, P.N.</author> <author>Rao, J.U.</author> <author>Timmers, H.J.L.M.</author> <author>Oude Ophuis, S.B.J.</author> <author>Lenders, J.W.M.</author> <author>Sweep, F.C.G.J.</author> <author>Wesseling, P.</author> <author>Kuster, B.</author> <author>Nederveen, F.H. van</author> <author>Krijger, R.R. de</author> <author>Hermus, A.R.M.M.</author>
    </item> <item>
      <title>Chlamydia trachomatis and placental inflammation in early preterm delivery (Article)</title>
      <link>http://repub.eur.nl/res/pub/25491/</link>
      <pubDate>2011-05-01T00:00:00Z</pubDate>
      <description>
        
        Chlamydia trachomatis may infect the placenta and subsequently lead to preterm delivery. Our aim was to evaluate the relationship between the presence of Chlamydia trachomatis and signs of placental inflammation in women who delivered at 32 weeks gestation or less. Setting: placental histology and clinical data were prospectively obtained from 304 women and newborns at the Erasmus MC-Sophia, Rotterdam, the Netherlands. C. trachomatis testing of placentas was done retrospectively using PCR. C. trachomatis was detected in 76 (25%) placentas. Histological evidence of placental inflammation was present in 123 (40%) placentas: in 41/76 (54%) placentas with C. trachomatis versus 82/228 (36%) placentas without C. trachomatis infection (OR 2.1, 95% CI 1.2-3.5). C. trachomatis infection correlated with the progression (P = 0.009) and intensity (P = 0.007) of materno-fetal placental inflammation. C. trachomatis DNA was frequently detected in the placenta of women with early preterm delivery, and was associated with histopathological signs of placental inflammation. 
      </description>
      <author>Rours, G.I.J.G.</author> <author>Krijger, R.R. de</author> <author>Ott, A.</author> <author>Willemse, H.F.</author> <author>Groot, R. de</author> <author>Zimmermann, L.J.I.</author> <author>Kornelisse, R.F.</author> <author>Verbrugh, H.A.</author> <author>Verkooijen, R.P.</author>
    </item> <item>
      <title>Decreasing prevalence of oral cleft live births in the Netherlands, 1997-2006 (Article)</title>
      <link>http://repub.eur.nl/res/pub/26470/</link>
      <pubDate>2011-05-01T00:00:00Z</pubDate>
      <description>
        
        Objectives: The number of new oral cleft patients has fallen in the Netherlands. This may be explained by two hypotheses: (1) greater prenatal detection of congenital anomalies has led to more pregnancy terminations and (2) increased folic acid use has reduced the oral cleft risk. Both hypotheses would mainly apply to the category cleft lip/alveolus ± cleft palate (CL±P), since, unlike cleft palate only (CP), CL±P can be detected prenatally by two-dimensional (2D) ultrasound and develops during the period recommended for folic acid use. The authors aimed to determine trends in prevalence over 1997-2006 and to evaluate the hypotheses by stratifying trends by cleft category. Methods: This study was a time-trend analysis of infants born alive with oral clefts in the Netherlands during 1997-2006 and registered in the national oral cleft registry. The authors calculated prevalence rates and the estimated annual percentage change (EAPC) for all oral clefts and the two categories. Results: In 1997-2006, 3308 infants out of 1 970 872 live births had oral clefts, an overall prevalence per 10 000 live births of 16.8 (CL±P: 11.3; CP: 5.5). Time-trend analysis showed that the prevalence of all oral clefts decreased (EAPC -1.8%; 95% CI: -3.0% to -0.6%), as did the CL±P prevalence (EAPC -2.3%; 95% CI: -3.8% to -0.9%). No significant trends were found for the CP prevalence. Conclusions: Because the live-birth prevalence of CL±P decreased, that of all oral clefts decreased. These findings are in line with both hypotheses and may therefore have implications for prenatal counselling and folic acid policy.
      </description>
      <author>Rozendaal, A.M.</author> <author>Luijsterburg, A.J.M.</author> <author>Ongkosuwito, E.M.</author> <author>Vries, E. de</author> <author>Vermeij-Keers, C.</author>
    </item> <item>
      <title>A review of topical negative pressure therapy in wound healing: Sufficient evidence? (Article)</title>
      <link>http://repub.eur.nl/res/pub/25498/</link>
      <pubDate>2011-04-01T00:00:00Z</pubDate>
      <description>
        
        Background Topical negative pressure (TNP) therapy has become a useful adjunct in the management of various types of wounds. However, the TNP system still has characteristics of a "black box" with uncertain efficacy for many users. We extensively examined the effectiveness of TNP therapy reported in research studies. Data sources A database search was undertaken, and over 400 peer-reviewed articles related to the use of TNP therapy (animal, human, and in vitro studies) were identified. Conclusions Almost all encountered studies were related to the use of the commercial VAC device (KCI Medical, United States). Mechanisms of action that can be attributed to TNP therapy are an increase in blood flow, the promotion of angiogenesis, a reduction of wound surface area in certain types of wounds, a modulation of the inhibitory contents in wound fluid, and the induction of cell proliferation. Edema reduction and bacterial clearance, mechanisms that were attributed to TNP therapy, were not proven in basic research. 
      </description>
      <author>Mouës, C.M.</author> <author>Heule, F.</author> <author>Hovius, S.E.R.</author>
    </item> <item>
      <title>Survival of pedicled pectoralis major flap after secondary myectomy of muscle pedicle including transection of thoracoacromial vessels: Does the flap remain dependent on its dominant pedicle? (Article)</title>
      <link>http://repub.eur.nl/res/pub/23094/</link>
      <pubDate>2011-03-01T00:00:00Z</pubDate>
      <description>
        
        Background: The pectoralis major (PM) flap is a frequently used flap for head and neck reconstructions. The muscle is easy to transpose on the dominant thoracoacromial bundle and has relative low morbidity. Some patients complain of pain and restricted neck motion after PM flap transposition. Secondary contraction due to radiotherapy, atrophy or insufficient denervation during transposition can be causes for this function deficit. In a series of ten patients we analysed the causes of this contraction and show the results of secondary myectomy of the PM pedicle with transection of the thoracoacromial bundle. Methods: Between 2000 and 2008 a total of 12 myectomies were performed in ten patients. Indication, radiation, denervation of the PM, and follow-up before and after myectomy were analysed retrospectively. Results: Indications for PM flap reconstruction were floor of mouth malignancy, covering of neck wound, (osteo)radionecrosis, and larynx fistula. In six cases the PM muscle was denervated primarily. Seven patients received preoperative radiation on the wound bed. The interval between PM flap reconstruction and myectomy ranged from five months to seven years. There was no (partial) necrosis of the PM flaps after myectomy (median follow-up 15 months). All patients were satisfied with the result of myectomy. Conclusion: Myectomy of the PM pedicle with transection of the thoracoacromial bundle after muscle transposition is an effective method to treat secondary neck contracture. The procedure is safe, regardless of pre- or postoperative radiotherapy. Our results question the general accepted theory that muscle flaps remain dependent on their dominant pedicle.
      </description>
      <author>Rossen, M.E.E. van</author> <author>Verduijn, P.V.</author> <author>Mureau, M.A.M.</author>
    </item> <item>
      <title>Growth diagrams for individual finger strength in children measured with the RIHM (Article)</title>
      <link>http://repub.eur.nl/res/pub/24010/</link>
      <pubDate>2011-03-01T00:00:00Z</pubDate>
      <description>
        
        Background: Although grip and pinch strength provide a more global measure of a large number of digits and muscles, measuring strength of individual fingers or the thumb can provide additional and more detailed information regarding hand strength. Questions/purposes: We developed growth diagrams for individual finger strength in children. Patients and Methods: We measured thumb palmar abduction, thumb opposition, and thumb flexion in the metacarpophalangeal joint, and abduction of the index and little fingers in 101 children (4-12 years old) using a myometer. We recorded hand dominance, gender, height, and weight. All measurements were performed in a randomized order by the same researcher. We developed statistical models for drawing growth diagrams using estimated percentiles for each strength measurement. Separate models for dominant and nondominant hands of boys and girls were developed, in addition to a combined model. Results: Because there was no difference in strength between boys and girls and between dominant and non-dominant hands, both hands and genders were combined in one growth diagram for each measurement. The normative data were presented in a table format and in growth diagrams for each myometer measurement. Conclusions: These diagrams can be used for pediatric patients such as patients with congenital malformations or neuromuscular disorders who receive interventions or therapy aimed at function of the hand, fingers, or thumb. The growth diagrams facilitate distinguishing between the effects of growth and intervention on strength development. 
      </description>
      <author>Molenaar, H.M.</author> <author>Selles, R.W.</author> <author>Willemsen, S.P.</author> <author>Hovius, S.E.R.</author> <author>Stam, H.J.</author>
    </item> <item>
      <title>Nasal reconstruction after malignant tumor resection: An algorithm for treatment (Article)</title>
      <link>http://repub.eur.nl/res/pub/25158/</link>
      <pubDate>2011-03-01T00:00:00Z</pubDate>
      <description>
        
        
      </description>
      <author>Moolenburgh, S.E.</author> <author>McLennan, L.</author> <author>Levendag, P.C.</author> <author>Munte, K.</author> <author>Scholtemeijer, M.</author> <author>Hofer, S.O.P</author> <author>Mureau, M.A.M.</author>
    </item> <item>
      <title>Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15) (Article)</title>
      <link>http://repub.eur.nl/res/pub/23239/</link>
      <pubDate>2011-02-25T00:00:00Z</pubDate>
      <description>
        
        Mutations in the F-box only protein 7 gene (FBXO7) cause PARK15, an autosomal recessive neurodegenerative disease presenting with severe levodopa-responsive parkinsonism and pyramidal disturbances. Understanding the PARK15 pathogenesis might thus provide clues on the mechanisms of maintenance of brain dopaminergic neurons, the same which are lost in Parkinson's disease. The protein(s) encoded by FBXO7 remain very poorly characterized. Here, we show that two protein isoforms are expressed from the FBXO7 gene in normal human cells. The isoform 1 is more abundant, particularly in primary skin fibroblasts. Both isoforms are undetectable in cell lines from the PARK15 patient of an Italian family; the isoform 1 is undetectable and the isoform 2 is severely decreased in the patients from a Dutch PARK15 family. In human cell lines and mouse primary neurons, the endogenous or over-expressed, wild type FBXO7 isoform 1 displays mostly a diffuse nuclear localization. An intact N-terminus is needed for the nuclear FBXO7 localization, as N-terminal modification by PARK15-linked missense mutation, or N-terminus tag leads to cytoplasmic mislocalization. Furthermore, the N-terminus of wild type FBXO7 (but not of mutant FBXO7) is able to confer nuclear localization to profilin (a cytoplasmic protein). Our data also suggest that overexpressed mutant FBXO7 proteins (T22M, R378G and R498X) have decreased stability compared to their wild type counterpart. In human brain, FBXO7 immunoreactivity was highest in the nuclei of neurons throughout the cerebral cortex, intermediate in the globus pallidum and the substantia nigra, and lowest in the hippocampus and cerebellum. In conclusion, the common cellular abnormality found in the PARK15 patients from the Dutch and Italian families is the depletion of the FBXO7 isoform 1, which normally localizes in the cell nucleus. The activity of FBXO7 in the nucleus appears therefore crucial for the maintenance of brain neurons and the pathogenesis of PARK15.
      </description>
      <author>Zhao, T.</author> <author>Graaff, E. de</author> <author>Oostra, B.A.</author> <author>Bonifati, V.</author> <author>Breedveld, G.J.</author> <author>Loda, A.</author> <author>Severijnen, L.A.</author> <author>Wouters, C.H.</author> <author>Verheijen, F.W.</author> <author>Dekker, M.C.J.</author> <author>Montagna, P.</author> <author>Willemsen, R.</author>
    </item> <item>
      <title>Pressure relief, cold foam or static air? A single center, prospective, controlled randomized clinical trial in a Dutch nursing home (Article)</title>
      <link>http://repub.eur.nl/res/pub/22927/</link>
      <pubDate>2011-02-01T00:00:00Z</pubDate>
      <description>
        
        Objective: At present, the evidence regarding the type of mattress that is the best for preventing pressure ulcers is not convincing. In a single center, prospective, controlled trial we compared a static air overlay mattress (no electric pump needed) on top of a cold foam mattress with a cold foam mattress alone on pressure ulcer incidence in nursing home residents. Methods: 83 Patients were included in the study with a score lower than 12 points on the Norton scale and no pressure ulcer at the start of the study. 42 Patients received a cold foam mattress and 41 patients received a static air overlay on top of that cold foam mattress. Out of bed we standardized the pressure reduction in sitting position by using a static air cushion in both groups. Patients were checked weekly in both groups for pressure ulcers. Only when there were signs of developing a pressure ulcer grade 2 or higher, repositioning by our nursing home pressure ulcer protocol (PU protocol) was put into practice. Results: Seven patients (17.1%) on a cold foam mattress and two (4.8%) on a static air mattress developed a pressure ulcer grade 2 or more. There was no difference regarding pressure ulcer incidence between patients with a high risk (Norton 5-8) and patients with a medium risk (Norton 9-12). In 5 out of 7 patients who developed a pressure ulcer on a foam mattress the ulcers showed no healing using our PU protocol. In the static air group all pressure ulcers healed by regular treatment according to our PU protocol. Conclusions: In this study, static air overlay mattresses provided a better prevention than cold foam mattresses alone (4.8% versus 17.1%). The Norton scores of the patients in both groups did not change during the 6 month trial period. Our decision to use repositioning only when there were signs of a pressure ulcer seems to be acceptable when a static air overlay is in position. However, the score of 17.1% development (incidence) of pressure ulcers in the foam group may stress the need of repositioning when using only this type of mattress.
      </description>
      <author>Leen, M. van</author> <author>Hovius, S.E.R.</author> <author>Neyens, J.</author> <author>Halfens, R.J.G.</author> <author>Schols, J.M.G.A.</author>
    </item> <item>
      <title>Decision making in reconstruction of defects of the eyelid (Article)</title>
      <link>http://repub.eur.nl/res/pub/25484/</link>
      <pubDate>2011-02-01T00:00:00Z</pubDate>
      <description>
        
        We present three patients with major defects of the eyelid who subsequently had them reconstructed. They included a defect of the lateral upper lid, a defect of the medial upper and lower lids, and a defect of the medial lower lid, cheek, and nose. 
      </description>
      <author>Ferguson, N.M.</author> <author>Mathijssen, I.M.J.</author> <author>Hofer, S.O.P</author> <author>Mureau, M.A.M.</author>
    </item> <item>
      <title>The use of mesh in acute hernia: frequency and outcome in 99 cases (Article)</title>
      <link>http://repub.eur.nl/res/pub/25134/</link>
      <pubDate>2011-01-24T00:00:00Z</pubDate>
      <description>
        
        Background: Incarceration of inguinal, umbilical and cicatricial hernias is a frequent problem. However, little is known about the relationship between the use of mesh and outcome after surgery. The goal of this study was to describe the relationship between the use of mesh in incarcerated hernia and the clinical outcome. Patients and methods: Correspondence, operation reports and patient files between January 1995 and December 2005 of patients presented at one academic and one teaching hospital in Rotterdam were searched for the following keywords: incarceration, strangulation and hernia. The patient characteristics, clinical presentation, pre-operative findings and clinical course were scored and analysed. Results: A total of 203 patients could be identified: 76 inguinal, 52 umbilical, 39 incisional, 14 epigastric, 14 femoral, five trocar and three spigelian hernias. In the statistical analysis, epigastric, femoral, trocar and spigelian hernias were pooled, due to their small group sizes. One patient was excluded from the analysis because the hernia was not corrected during operation. In total, 99 hernias were repaired using mesh versus 103 primary suture repairs. Twenty-five wound infections were registered (12.3%). One mesh was removed during a reintervention for anastomotic leakage, although no signs of wound infection were present. Nine patients died, none of them due to wound-related problems [one cardiovascular, one ruptured aneurysm, two anastomotic leakage, two sepsis e causa incognita (e.c.i.), three pulmonary complications]. Univariate analysis showed that female patients (P = 0.007), adipose patients (P = 0.016), patients with an umbilical hernia (P = 0.01) and patients who underwent a bowel resection (P = 0.015) had a significantly higher rate of wound infections. The type of repair (e.g. primary suture or mesh), use of antibiotic prophylaxis, gender, ASA class and age showed no significant relation with post-operative wound infection. After logistic regression analysis, only bowel resection (P = 0.020) showed a significant relation with post-operative wound infection. Conclusions: Wound infection rates are high after the correction of acute hernia, but clinical consequences are relatively low. Mesh correction of an acute hernia seems to be safe and should be considered in every incarcerated hernia. 
      </description>
      <author>Nieuwenhuizen, J.</author> <author>Ramshorst, G.H. van</author> <author>Brinke, J.G. ten</author> <author>Wit, T. de</author> <author>Harst, E. van der</author> <author>Hop, W.C.J.</author> <author>Jeekel, J.</author> <author>Lange, J.F.</author>
    </item> <item>
      <title>Engineering Vascularized Adipose Tissue (Doctoral Thesis)</title>
      <link>http://repub.eur.nl/res/pub/22186/</link>
      <pubDate>2011-01-07T00:00:00Z</pubDate>
      <description>
        
        A large portion of the plastic and reconstructive surgical procedures performed each
year is aimed at repairing soft tissue defects, which result for example from traumatic
injury or tumor resections. Large soft tissue defects, lead to a change in function
and ‘normal’ body contour, which in its turn can lead to disability and emotional stress. Currently used methods to repair soft tissue defects include the use of autologous
adipose tissue transplants and synthetic implants. Both procedures have their own
advantages and drawbacks.
      </description>
      <author>Verseijden, F.</author>
    </item> <item>
      <title>Surgical management of neuroma pain: A prospective follow-up study (Article)</title>
      <link>http://repub.eur.nl/res/pub/21647/</link>
      <pubDate>2010-12-01T00:00:00Z</pubDate>
      <description>
        
        Painful neuromas can cause severe loss of function and have great impact on the daily life of patients. Surgical management remains challenging; despite improving techniques, success rates are low. To accurately study the success of surgical neuroma treatment and factors predictive of outcome, a prospective follow-up study was performed. Between 2006 and 2009, pre- and post-operative questionnaires regarding pain (VAS, McGill), function (DASH), quality of life (SF-36), symptoms of psychopathology (SCL-90), epidemiologic determinants and other outcome factors were sent to patients surgically treated for upper extremity neuroma pain. Pain scores after diagnostic nerve blocks were documented at the outpatient clinic before surgery. Thirty-four patients were included, with an average follow up time of 22 months. The mean VAS score decreased from 6.8 to 4.9 after surgery (p &lt; 0.01), 19 (56%) of patients were satisfied with surgical results. Upper extremity function improved significantly (p = 0.001). Neuroma patients had significantly lower quality of life compared to a normal population. Employment status, duration of pain and CRPS symptoms were found to be prognostic factors. VAS scores after diagnostic nerve block were predictive of post-operative VAS scores (p = 0.001). Furthermore, smoking was significantly related to worse outcome (relative risk: 2.10). The results could lead to improved patient selection and treatment strategies. If a diagnostic nerve block is ineffective in relieving pain, patients will most likely not benefit from surgical treatment. Patients should be encouraged to focus on activity and employment instead of their symptoms. Smoking should be discouraged in patients who will undergo surgical neuroma treatment.
      </description>
      <author>Stokvis, A.</author> <author>Avoort, D-J.J.C.</author> <author>Neck, J.W. van</author> <author>Hovius, S.E.R.</author> <author>Coert, J.H.</author>
    </item> <item>
      <title>Delay of denervation atrophy by sensory protection in an end-to-side neurorrhaphy model: A pilot study (Article)</title>
      <link>http://repub.eur.nl/res/pub/21894/</link>
      <pubDate>2010-12-01T00:00:00Z</pubDate>
      <description>
        
        Object: Temporary sensory innervation delays the atrophy process. A major disadvantage of most experimental models is that sensory-protected muscles must be denervated a second time to allow reinnervation by the affected nerve. The aim of this study was to assess the effect of sensory protection on denervated gastrocnemius muscle in an end-to-side neurorrhaphy model, in which denervated muscles may be preserved until axons of the native nerve reach their target without the necessity for a second operation. Methods: The tibial nerve of 24 female Lewis rats was transected. Twelve animals acted as the controls. In the other 12 animals, the end of the sural nerve was connected to the side of the distal tibial nerve stump (sensory protection group). At 5 and 10 weeks, wet gastrocnemius muscle weight was reported as a ratio of the operated to the unoperated side. For histological analysis, muscle samples were rapidly frozen and sections were stained with haematoxylin and eosin, Oil Red O stain and modified Gomori trichrome stain. Results: The difference between the sensory protection group and the control group was statistically significant at 5 (0.36 ± 0.01 and 0.29 ± 0.01, respectively; p &lt; 0.001) and 10 weeks postoperatively (0.28 ± 0.01 and 0.19 ± 0.00, respectively; p &lt; 0.001). Histological observations revealed that sensory-protected muscles underwent less atrophy. Conclusion: Sensory protection delays atrophy in an end-to-side neurorrhaphy model.
      </description>
      <author>Zuijdendorp, H.M.</author> <author>Tra, W.M.W.</author> <author>Neck, J.W. van</author> <author>Mollis, L.</author> <author>Coert, J.H.</author>
    </item>
  </channel>
</rss>